Evans MDS Summit
The EvansMDS MDS Summit 2023
October 12 & 13th, 2023, The Brown Hotel, Louisville, KY.
We’ll be continuing our tradition of getting together in-person for discussions of the latest results from our ground-breaking group of funded investigators. Look forward to many lively discussions and and a heated exchange of ideas as we work together to advance our understanding of the disease pathophysiology and potential treatments for MDS. This is an invitation-only meeting – the best way to get an invitation is to apply to our Discovery Research or EvansMDS Young Investigator grant programs.
In addition to sponsoring our own MDS Summits, EvansMDS provides support for meetings organized by other organizations which cover important aspects of MDS medical research.
Past meetings include:
Thirteenth International Workshop on the Molecular Aspects of Myeloid Stem Cell Development and Leukemia
MDS Summit 2021 (virtual)
MDS Summit 2020 (virtual)
Splicing Factor Mutations and RNA Biology In Cancer Workshop 2019
Twelfth International Workshop on the Molecular Aspects of Myeloid Stem Cell Development and Leukemia
Workshop on Splicing Factor Mutations in Cancer (October 29 – 30, 2016)
Eleventh International Workshop on the Molecular Aspects of Myeloid Stem Cell Development and Leukemia
Tenth International Workshop on the Molecular Aspects of Myeloid Stem Cell Development and Leukemia
Collaboration is Critical for the Advancement of MDS Therapies
Mr. Evans was frustrated by the siloed nature of medical research. He believed that collaboration between specialized researchers was critical to achieving rapid progress and realizing significant patient benefits. EvansMDS extends this vision through the specifics of our granting process and through our sponsorship of important meetings of MDS researchers pursuing cutting edge topics. These meetings allow researchers to share their unpublished work within the MDS community to obtain valuable peer feedback as well as to provide opportunities for the acceleration of new discoveries through the synergistic combination of laboratories working on complementary investigations, or with access to alternative patient populations, supporting data, techniques, or samples.